Kalaris Therapeutics (KLRS) Research & Development (2019 - 2026)
Kalaris Therapeutics' Research & Development was $9.02 million in Q2 2026, up 6.8% from $8.44 million a year earlier and up 19.1% from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Research & Development (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Kalaris Therapeutics' Research & Development was $32.87 million through Jun 30, 2026, down 39.5% year-over-year; for FY2025, it was $30.75 million, down 31.7% from FY2024.
- Research & Development shows a five-year compound annual growth rate of -9.1% (FY2020 to FY2025).
- In earlier years, Research & Development was $45.04 million in FY2024 (-66.2%), $133.07 million in FY2023 (+11.9%), $118.87 million in FY2022 (-1.5%) and $120.74 million in FY2021 (+143.1%).
- Quarterly Research & Development has moved between $1.96 million (Q1 2024) and $41.6 million (Q4 2021) over five years.
- Compared with a year earlier, Research & Development has increased for three straight quarters, with growth averaging 41.4% over the last eight quarters.
- The best year-over-year quarter for Research & Development over five years was Q1 2025 (growth of 207.5%); the worst was Q1 2024 (a decline of 93.6%).
- Per Business Quant data, KLRS's Research & Development in the three quarters before Q2 2026 was $7.57 million (Q1 2026), $7.16 million (Q4 2025) and $9.13 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.33 Bn | 1,106.91 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 618.82 Bn | 537.35 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.36 Bn | 476.47 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 369.59 Bn | 323.96 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.57 Bn | 262.56 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.25 Bn | 234.94 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.35 Bn | 192.75 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.27 Bn | 165.47 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.03 Bn | 116.68 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Kalaris Therapeutics | 47.36 Mn | -46.14 Mn | - | 9.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.02 Mn |
| Mar 31, 2026 | 7.57 Mn |
| Dec 31, 2025 | 7.16 Mn |
| Sep 30, 2025 | 9.13 Mn |
| Jun 30, 2025 | 8.44 Mn |
| Mar 31, 2025 | 6.03 Mn |
| Dec 31, 2024 | 3.85 Mn |
| Sep 30, 2024 | 36.02 Mn |
| Jun 30, 2024 | 3.21 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Dec 31, 2023 | 33.37 Mn |
| Sep 30, 2023 | 34.16 Mn |
| Jun 30, 2023 | 34.82 Mn |
| Mar 31, 2023 | 30.72 Mn |
| Dec 31, 2022 | 28.42 Mn |
| Sep 30, 2022 | 30.00 Mn |
| Jun 30, 2022 | 31.38 Mn |
| Mar 31, 2022 | 29.07 Mn |
| Dec 31, 2021 | 41.60 Mn |
| Sep 30, 2021 | 33.06 Mn |
API Access
Kalaris Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();